Search

Your search keyword '"Pecoits-Filho, Roberto"' showing total 1,536 results

Search Constraints

Start Over You searched for: Author "Pecoits-Filho, Roberto" Remove constraint Author: "Pecoits-Filho, Roberto"
1,536 results on '"Pecoits-Filho, Roberto"'

Search Results

51. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil

56. Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps

58. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

59. Standardized Outcomes in Nephrology—Peritoneal Dialysis (SONG-PD): Study Protocol for Establishing a Core Outcome Set in PD

60. Optimizing home visits through machine learning for preventing peritoneal dialysis-associated peritonitis: a proof of concept study and results from PDOPPS

64. WCN24-911 PUTTING IRON DEFICIENCY FRONT AND CENTER: TRANSFERRIN SATURATION AMONG INCIDENT PERITONEAL DIALYSIS PATIENTS AND MORTALITY RISK

65. WCN24-2160 SUBSTANTIAL SEX DIFFERENCES IN PERITONEAL DIALYSIS OUTCOMES: RESULTS FROM PDOPPS

66. WCN24-1543 PATIENTS’ PERSPECTIVE OF THE IMPACT OF CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE DISCOVER CKD QUALITATIVE STUDY

67. WCN24-1574 HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE DISCOVER CKD PROSPECTIVE STUDY

69. Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

70. International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS

71. Nephrologists’ perspectives on communication and decision-making regarding technique survival in peritoneal dialysis: an international qualitative interview study

72. Risk of Kidney Failure and Mortality in Patients Under Nephrology Care in NonHigh-Income Settings

75. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion

76. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

77. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

79. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

80. Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries

81. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria

82. Efficacy and Safety of Dapagliflozin in Patients with Chronic Kidney Disease across the Spectrum of Frailty

83. Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes.

84. Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD

85. Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

88. Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

91. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

92. CKD-Associated Pruritus and Clinical Outcomes in Nondialysis CKD

99. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review

Catalog

Books, media, physical & digital resources